Smithfield Trust’s iShares Biotechnology ETF IBB Stock Holding History

Smithfield Trust’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$136K	Hold	800	–	–	0.01%	432
2025 Q4	$136K	Hold	800	–	–	0.01%	427
2025 Q3	$115K	Sell	800 -16	-2%	-$2.18K	0.01%	441
2025 Q2	$102K	Buy	816 +16	+2%	+$1.96K	﹤0.01%	444
2025 Q1	$103K	Hold	800	–	–	0.01%	436
2024 Q4	$107K	Hold	800	–	–	0.01%	432
2024 Q3	$117K	Hold	800	–	–	0.01%	435
2024 Q2	$110K	Sell	800 -75	-9%	-$10K	0.01%	425
2024 Q1	$120K	Hold	875	–	–	0.01%	415
2023 Q4	$119K	Hold	875	–	–	0.01%	403
2023 Q3	$108K	Hold	875	–	–	0.01%	402
2023 Q2	$112K	Hold	875	–	–	0.01%	404
2023 Q1	$113K	Hold	875	–	–	0.01%	397
2022 Q4	$116K	Hold	875	–	–	0.01%	376
2022 Q3	$102K	Hold	875	–	–	0.01%	383
2022 Q2	$102K	Hold	875	–	–	0.01%	405
2022 Q1	$113K	Hold	875	–	–	0.01%	412
2021 Q4	$133K	Hold	875	–	–	0.01%	394
2021 Q3	$142K	Hold	875	–	–	0.01%	369
2021 Q2	$143K	Buy	875 +195	+29%	+$30K	0.01%	377
2021 Q1	$102K	Buy	680 +80	+13%	+$12.7K	0.01%	438
2020 Q4	$91K	Hold	600	–	–	0.01%	443
2020 Q3	$81K	Hold	600	–	–	0.01%	433
2020 Q2	$82K	Hold	600	–	–	0.01%	415
2020 Q1	$65K	Hold	600	–	–	0.01%	405
2019 Q4	$72K	Hold	600	–	–	0.01%	451
2019 Q3	$60K	Buy	+600	New	+$62.8K	0.01%	494
2017 Q3	–	Sell	-261	Closed	-$27K	–	814
2017 Q2	$27K	Sell	261 -261	-50%	-$25.7K	﹤0.01%	613
2017 Q1	$51K	Sell	522 -1,068	-67%	-$102K	0.01%	522
2016 Q4	$141K	Hold	1,590	–	–	0.02%	347
2016 Q3	$153K	Hold	1,590	–	–	0.03%	323
2016 Q2	$136K	Hold	1,590	–	–	0.03%	336
2016 Q1	$139K	Buy	1,590 +168	+12%	+$15K	0.03%	330
2015 Q4	$160K	Hold	1,422	–	–	0.03%	308
2015 Q3	$144K	Hold	1,422	–	–	0.03%	323
2015 Q2	$175K	Hold	1,422	–	–	0.03%	308
2015 Q1	$163K	Buy	1,422 +300	+27%	+$33.1K	0.03%	346
2014 Q4	$113K	Hold	1,122	–	–	0.02%	375
2014 Q3	$102K	Sell	1,122 -3	-0.3%	-$263	0.02%	391
2014 Q2	$96K	Hold	1,125	–	–	0.02%	453
2014 Q1	$89K	Hold	1,125	–	–	0.02%	462
2013 Q4	$85K	Buy	1,125 +600	+114%	+$42.6K	0.02%	452
2013 Q3	$37K	Hold	525	–	–	0.01%	530
2013 Q2	$30K	Buy	+525	New	+$30.3K	0.01%	532

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Smithfield Trust's IBB Position: Q1 2026 in Review

Smithfield Trust held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 800 shares worth $136K. The position accounts for 0.01% of the portfolio, ranked #432.

Smithfield Trust first reported a position in IBB in Q2 2013 and has held it in 44 quarters since. The position peaked at $175K in Q2 2015. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

Smithfield Trust held 800 shares of iShares Biotechnology ETF worth $136K as of Q1 2026.
Smithfield Trust left its iShares Biotechnology ETF share count unchanged in Q1 2026.
iShares Biotechnology ETF made up 0.01% of Smithfield Trust's portfolio in Q1 2026, its #432 holding.
Smithfield Trust first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 44 quarters since.
Smithfield Trust's iShares Biotechnology ETF position peaked at $175K in Q2 2015.
917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Smithfield Trust's 13F filing for Q1 2026, filed 8 May 2026.